Literature DB >> 3932748

[Long-term therapy of familial hypercholesterolemia in young patients with colestipol: availability of minerals and vitamins].

G Schlierf, G Vogel, M Kohlmeier, J P Vuilleumier, R Hüppe, H Schmidt-Gayk.   

Abstract

Longterm treatment for 5 years of young patients with familial hypercholesterolemia was accompanied by monitoring of plasma levels of calcium, iron, sodium, parathyroid hormone and water- and fat soluble vitamins, since interference of the ion exchange resin with absorption of numerous substances as well as abnormal plasma levels of some of the above had been described in several studies. Treatment was effective in the group with good compliance (lowering of plasma cholesterol at the end of 5 years by 19% and, compared to the control group, by 23%). Adverse drug effects with respect to the above parameters were not found. Plasma levels of carotinoides and vitamin E were elevated in the patients according to elevated concentrations of lipoproteins which are carriers of these vitamins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3932748     DOI: 10.1007/bf01732284

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  23 in total

1.  [Dietary management of familial Hypercholesterolemia in Children and adolescents -- a feasibility study (author's transl)].

Authors:  G Schlierf; G Vogel; C C Heuck; P Oster; H Raetzer; B Schellenberg
Journal:  Monatsschr Kinderheilkd       Date:  1977-08

2.  Sitosterol in juvenile type II hyperlipoproteinemia.

Authors:  G Schlierf; P Oster; C C Heuck; H Raetzer; B Schellenberg
Journal:  Atherosclerosis       Date:  1978-08       Impact factor: 5.162

3.  [Relation between beta-lipoprotein content in serum and plasma vitamin E content. A contribution to the question of the estimation of the vitamin E status in man].

Authors:  G Brubacher; H B Stähelin; J P Vuilleumier
Journal:  Int J Vitam Nutr Res       Date:  1974       Impact factor: 1.784

4.  [Familial hypercholesterolemia. Problems of patients in dealing with their disease].

Authors:  O Seidl; C Keller; H Pfleger; G Wolfram; N Zöllner
Journal:  MMW Munch Med Wochenschr       Date:  1982-09-24

5.  [Arterial occlusive diseases in children and adolescents with familial hypercholesterolemia].

Authors:  D Matthes; A Wirth; G Klose; H Mörl; G Schlierf
Journal:  Vasa       Date:  1980       Impact factor: 1.961

6.  Vitamin distribution in human plasma proteins.

Authors:  H Baker; O Frank; S Feingold; C M Leevy
Journal:  Nature       Date:  1967-07-01       Impact factor: 49.962

Review 7.  Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.

Authors:  R C Heel; R N Brogden; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-03       Impact factor: 9.546

8.  [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].

Authors:  R Mordasini; F Twelsick; P Oster; B Schellenberg; H Raetzer; C C Heuck; G Schlierf
Journal:  Monatsschr Kinderheilkd       Date:  1978-07

9.  Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol.

Authors:  K B Schwarz; P D Goldstein; J L Witztum; G Schonfeld
Journal:  Pediatrics       Date:  1980-02       Impact factor: 7.124

10.  Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine.

Authors:  R J West; J K Lloyd; J V Leonard
Journal:  Lancet       Date:  1980-10-25       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.